Spreadex Market Update
Euro stays below weekly highs, Musk’s mission to link computers with the brain
Today’s trading has seen the euro inch slightly higher; however, it remains nearly a cent lower from its weekly high against the US dollar.
There didn’t appear to be any reaction from the markets to the terrorist attack in Paris last night with the EUR/USD currency pair currently trading around the $1.07 mark.
Investors are no doubt preparing for Sunday’s election where it is thought that while right wing candidate Marine Le Pen will most likely win enough votes to make it to the second round of voting, she will then be comfortably beaten in the second round, with centrist candidate Emmanuel Macron the likely winner at the moment.
If this is the case, expect to see a bullish market in early trading next week. This sentiment is backed by Mark Dowding, partner at BlueBay Asset Management in London, who was quoted as saying, "On the assumption that the French election will provide a market-friendly winner, we believe that euro zone assets may be poised to rally strongly in the next few weeks as political risk declines”.
However, it goes without saying that any election poll must now be taken with a very healthy portion of salt!
In other news, Tesla founder Elon Musk has indicated he is working to create a link between a machine interface and the human brain. This will be worked on by his latest company, Neuralink, whose aim it is to develop a micron sized device that will provide a direct link between computers and the neurones in our brain.
Musk’s thinking is that eventually artificial intelligence will become so advanced that we will need devices such as the one proposed by Neuralink just to keep up; a scary thought indeed!
The Wall Street Journal reported the launch of the “medical research” company last month claiming Musk will mainly fund it himself. Nevertheless, this could change in the future and so is definitely one to keep an eye on.
It's easy to open an account
- Fill in our simple online application form
- Fund your account
- Start trading the global markets instantly!
SEARCH FOR AN ARTICLE:
Enter a keyword and search for all relevant articlesMARKET ANALYSIS
RECENT POSTS
DISCLAIMER
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.
Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.
No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.
The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.